Prof Ben Tran
Honorary Conjoint Professorial Fellow
The Sir Peter MacCallum Department of Oncology
470 Scholarly works
11 Projects
HIGHLIGHTS
2026
Journal article
Dynamic immune profiling predicts response to radiation plus anti-PD-1 therapy in oligometastatic renal cell carcinoma
DOI: 10.1038/s41467-026-74255-x2026
Journal article
A roadmap for establishing institutional readiness for cellular therapies targeting solid tumours and autoimmune diseases
DOI: 10.1038/s41698-026-01462-62026
Journal article
Leveraging Real-World Evidence to Drive Advances in Oncology Care in the Asia-Pacific Region: Recommendations From the Asia-Pacific Oncology Drug Development Consortium Working Group.
DOI: 10.1200/GO-26-002172026
Journal article
Full enrollment results from cohort 1 of the phase III randomized THOR trial of erdafitinib versus chemotherapy in FGFR-altered advanced urothelial carcinoma.
DOI: 10.1016/j.esmoop.2026.1085832022
Research grants (ARC, NHMRC, MRFF)
Targeting Cold Tumours With Triple Therapy
2019
Research Grant
PRECEPT - PRostatE CancEr Prognosis and Treatment
2017
Research Grant
Combination of Radionuclide 177lu-Psma Therapy With Pembrolizumab in Patients With Metastatic Castration-Resistant Prostate Cancer (Mcrpc)
RECENT SCHOLARLY WORKS
2026
Journal article
Treatment Patterns and Survival Outcomes in a Real-World Cohort of Lutetium 177 Vipivotide Tetraxetan (LuPSMA)-Experienced Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC)
DOI: 10.1016/j.clgc.2026.1026092026
Journal article
Intravesical cretostimogene grenadenorepvec oncolytic immunotherapy in high-risk, BCG-unresponsive, non-muscle-invasive bladder cancer with carcinoma in situ (BOND-003 Cohort C): a single-arm, phase 3 trial
DOI: 10.1016/S1470-2045(26)00194-42026
Journal article
Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy from a First-in-Human Study of Volrustomig, a Novel PD-1/CTLA-4 Bispecific Antibody
DOI: 10.1158/1078-0432.CCR-25-34472026
Journal article
Advances in cancer immunotherapy: adoptive cell therapy and immune cell engagers in solid tumours
DOI: 10.1038/s41416-026-03450-w2026
Journal article
A simple plan: chemotherapy-sparing approaches to early-stage and regional seminoma and nonseminoma
DOI: 10.1016/j.annonc.2026.04.0052026
Journal article
Metastasis-directed Therapy With or Without Pembrolizumab for Oligometastatic Clear Cell Renal Cell Carcinoma: Pooled Analysis of Two Prospective Single-arm Phase 2 Trials
DOI: 10.1016/j.eururo.2026.03.024
RECENT PROJECTS
2024
Research grants (other domestic)
Stereotactic Ablative Body Radiotherapy (SABR) for 4 Gynaecologic Metastases
2024
Research grants (ARC, NHMRC, MRFF)
P3BEP Trial - Accelerating First-Line Chemotherapy to Improve Cure Rates for Advanced Germ Cell Tumours - An Australian-Led, International Randomised Trial